TriSalus Life Sciences Rings the Nasdaq Stock Market Opening Bell
TriSalus Life Sciences® Inc., an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Mary Szela, CEO, rings the Opening Bell.